Latest News

December 20, 2023

The November/December 2023 News from ECOG-ACRIN blog is now available

December 20, 2023

National cooperative groups, together with Conquer Cancer® and the Bristol Myers Squibb Foundation, announce the first group of oncology physicians ​selected for the Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Award in ​​Oncology

December 20, 2023

Video: Can patients with DCIS avoid radiation therapy?

December 20, 2023

Oncotype DX shows value in interim results from two radiation trials at the San Antonio Breast Cancer Symposium

December 11, 2023

Dr. Seema Khan on optimizing local therapy using MRI and a 12-gene expression assay in DCIS

December 11, 2023

BreastCancer.org Podcast: Dr. Seema Khan explains how a genomic test helps decide which DCIS needs radiation

December 11, 2023

Women with very early breast cancer may safely skip radiation Rx

December 11, 2023

Press Release: Encouraging results in mantle cell lymphoma from PrECOG

November 27, 2023

FDA announces grants to ECOG-ACRIN and others for real world data projects


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
41

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group